Protective role of medroxyprogesterone acetate on N-methyl-N-nitrosourea-induced lymphomas in BALB/c female mice

In a previous paper we reported the occurrence of a high incidence of lymphomas in N-methyl-N-nitrosourea (MNU)-treated mice, in the course of an experiment of combined chemical-hormonal carcinogenesis in mammary gland, in which we used medroxyprogesterone acetate (MPA) and MNU in different treatmen...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pazos, P., Lanari, C., Molinolo, A.A.
Formato:	JOUR
Materias:	Lymphoma Medroxyprogesterone acetate Mice N-methyl-N-nitrosourea Progestins medroxyprogesterone acetate methylnitrosourea animal experiment animal model animal tissue article controlled study drug effect female immunocytochemistry incidence lymphoma mouse nonhuman priority journal protection Animals Female Immunohistochemistry Incidence Medroxyprogesterone 17-Acetate Methylnitrosourea Mice, Inbred BALB C
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_01452126_v25_n2_p165_Pazos
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Protective role of medroxyprogesterone acetate on N-methyl-N-nitrosourea-induced lymphomas in BALB/c female mice
Publicado: (2001)

Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice
por: Pazos, P., et al.

Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice
Publicado: (1998)

Insulin-like growth factor-I production and receptors in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
Publicado: (1990)

Insulin-like growth factor-I production and receptors in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
por: Elizalde, P.V., et al.

Transforming growth factor-β activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
por: Elizalde, Patricia Virginia, et al.
Publicado: (1990)

Transforming growth factor-β activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
por: Elizalde, P.V., et al.

Role of ACTH on the effect of medroxyprogesterone in brain stem serotonin
Publicado: (1978)

Role of ACTH on the effect of medroxyprogesterone in brain stem serotonin
por: Izquierdo, J.A., et al.

Expansion of CD11b⁺Ly6G⁺Ly6C<sup>int</sup> cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions
por: Spallanzani, Raúl Germán, et al.
Publicado: (2013)

Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas
Publicado: (1995)

Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas
por: Elizalde, P.V., et al.

Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model
Publicado: (2005)

Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model
por: Fabris, V.T., et al.

Induccion de adenocarcinomas mamarios por progestagenos en ratones BALB/c: Progresion del tumor hormono-dependiente al autonomo
Publicado: (1997)

Induccion de adenocarcinomas mamarios por progestagenos en ratones BALB/c: Progresion del tumor hormono-dependiente al autonomo
por: Lanari, C., et al.

Reversal of estrogen-resistance in murine mammary adenocarcinomas
por: Montecchia, M.F., et al.

Reversal of estrogen-resistance in murine mammary adenocarcinomas
Publicado: (1999)

Involvement of insulin-like growth factors-I and-II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas
por: Elizalde, P.V., et al.

Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions
por: Ziblat, Andrea, et al.
Publicado: (2013)

Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions
por: Spallanzani, R.G., et al.

Factores de crecimiento y oncogenes en adenocarcinomas mamarios inducidos por acetato de medroxyprogesterona en ratones BALB/c
Publicado: (1997)

Factores de crecimiento y oncogenes en adenocarcinomas mamarios inducidos por acetato de medroxyprogesterona en ratones BALB/c
por: Elizalde, P.V., et al.

Involvement of insulin-like growth factors-I and-II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas
Publicado: (1998)

Leukemia & lymphoma
Publicado: (1989)

Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: Role of the host microenvironment
por: Montero Girard, G., et al.

Image-guided radiotherapy and functional imaging in modern lymphoma management /
Publicado: (2010)

Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: Role of the host microenvironment
Publicado: (2007)

Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
por: Bottino, M.C., et al.

The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide
por: Salatino, Mariana, et al.
Publicado: (2012)

The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide
por: Zacarías Fluck, M.F., et al.

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Labriola, Leticia, et al.
Publicado: (2001)

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.
Publicado: (2001)

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insalia-like growth factor receptor in mammary tumor cells
por: Balãá, M.E., et al.
Publicado: (2001)

Progression of Chronic Lymphocytic Leukemia into Hodgkin Lymphoma during Ibrutinib treatment. Case Report
por: Heller , VB, et al.
Publicado: (2019)

Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
por: Bottino, María Cecilia, et al.
Publicado: (2011)

New forms of induction of apoptosis in aggressive lymphoma using peptides that interrupt the RAS / RAF interaction
por: Bergna, Cecilia, et al.
Publicado: (2019)

Diffuse primary cutaneous large B- cell lymphoma, leg type: case report
por: Villata , AC, et al.
Publicado: (2021)

The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies
por: Barreiro Arcos, María Laura
Publicado: (2016)